+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Veterinary Healthcare Market - Growth, Trends, and Forecast (2020 - 2025)

  • ID: 5174867
  • Report
  • August 2020
  • Region: North America
  • 80 pages
  • Mordor Intelligence
UP TO OFF
until Dec 31st 2020
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Idexx Laboratories
  • Merck & Co. Inc.
  • Novartis AG
  • Randox Laboratories Ltd
  • Virbac SA
  • Zoetis Inc.
  • MORE
North America is among the major regions across the world which highly support the healthcare of veterinary animals both in companion animals (e.g. dogs, cats, and horses) and production (e.g. cattle, pigs, sheep, poultry, etc.) animal species categories. A large population investing in pet insurance, across the developed markets, is driving growth in the market being studied. As per the American Pet Production Association’s (APPA) National pet owners survey, 2017-2018 reports, the United States is home to 89.7 million dogs; 94.2 million cats; and 7.6 million horses. Moreover, 68% of US households own pets, which is equal to 84.6 million homes, out of which 60.2 million households own dogs, 47.1 million houses own cats and 2.6 million houses own horses. With the rising number of owners, there is a growing demand for routine veterinary services which majorly drives the demand of the veterinary healthcare market in the United States.

Key Market Trends

Application in Poultry is Expected to Register a High CAGR

Good poultry health management is an important component of poultry production. Infectious disease-causing agents spread through flock very quickly because of the high stocking densities of commercially housed poultry. For poultry health management to be effective a primary aim must be to prevent the onset of disease or parasites, to recognize at an early stage the presence of disease or parasites, and to treat all flocks that are diseased or infested with parasites as soon as possible and before they develop into a serious condition or spread to other flocks.

This poultry healthcare is important as the production is increasing in North America. As per a 2019 report by the United States Department of Agriculture, the production from broilers, eggs, turkeys, and the value of sales from chickens have continuously increased in the United States over the past many years. This is due to more population preferring chicken and other poultry products or other meats like beef, especially in developed countries like the United States and Canada. This is expected to increase the demand for poultry healthcare, which will increase market growth.

Competitive Landscape

The United States (US) and Canada have a developed and well-structured health care system. These systems also encourage research and development. These policies encourage global players to enter the United States and Canada. As a result, these countries enjoy the presence of many global market players. As high and increasing demand is met by the presence of global players in the region, the market is further expected to increase.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Idexx Laboratories
  • Merck & Co. Inc.
  • Novartis AG
  • Randox Laboratories Ltd
  • Virbac SA
  • Zoetis Inc.
  • MORE
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Advanced Technology Leading to Innovations in Animal Healthcare
4.2.2 Increasing Initiatives by Governments and Animal Welfare Associations
4.2.3 Increasing Productivity at the Risk of Emerging Zoonosis
4.3 Market Restraints
4.3.1 High Costs Related to Animal Testing
4.3.2 Strict Regulations on Therapeutics
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 By Therapeutics
5.1.1.1 Vaccines
5.1.1.2 Parasiticides
5.1.1.3 Anti-infectives
5.1.1.4 Medical Feed Additives
5.1.1.5 Other Therapeutics
5.1.2 By Diagnostics
5.1.2.1 Immunodiagnostic Tests
5.1.2.2 Molecular Diagnostics
5.1.2.3 Diagnostic Imaging
5.1.2.4 Clinical Chemistry
5.1.2.5 Other Diagnostics
5.2 By Animal Type
5.2.1 Dogs and Cats
5.2.2 Horses
5.2.3 Ruminants
5.2.4 Swine
5.2.5 Poultry
5.2.6 Other Animal Types
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Boehringer Ingelheim International GmbH
6.1.2 Ceva Holdings Inc. (Ceva Animal Health Inc.)
6.1.3 Eli Lilly and Company (Elanco Animal Health)
6.1.4 Idexx Laboratories
6.1.5 Merck & Co. Inc.
6.1.6 Novartis AG
6.1.7 Randox Laboratories Ltd
6.1.8 Virbac SA
6.1.9 Zoetis Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Boehringer Ingelheim International GmbH
  • Ceva Holdings Inc. (Ceva Animal Health Inc.)
  • Eli Lilly and Company (Elanco Animal Health)
  • Idexx Laboratories
  • Merck & Co. Inc.
  • Novartis AG
  • Randox Laboratories Ltd
  • Virbac SA
  • Zoetis Inc.
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll